ICICI Lombard
ICICI Lombard Q4 FY25 earnings call: Revenue & Margins
Q4 FY25 earnings call: what management guided on revenue, margins and order book.
The short version
Expectation of mid-single-digit growth in new Motor sales, with continued competition impacting growth rates. The company expects a positive growth outlook for FY2026 amid some industry challenges.
From ICICI Lombard's Q4 FY25 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Expectation of mid-single-digit growth in new Motor sales, with continued competition impacting growth rates.
- Health segment projected to see double-digit growth, particularly in Retail Health due to new insurance adoption and inflationary effects.
- Commercial lines expected to rebound to double-digit growth, aided by improved Fire pricing discipline and increased government CAPEX.
- Anticipated overall Gross Direct Premium Income (GDPI) growth of about 8.3% in FY2025 with optimism for further growth in FY2026.
- Industry-wide impact of regulatory changes (1/n accounting) may cause subdued growth in H1 FY2026, with potential unwinding in H2 improving full-year growth.
2 more points from ICICI Lombard's call on revenue
Pro opens every point from 15K+ earnings calls
Profitability & Margins
See what ICICI Lombard said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
Top-ranked in Insurance
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what ICICI Lombard said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
ICICI Lombard — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹6.8K Cr, net profit ₹547 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What ICICI Lombard's management said in earlier quarters
- Q2 FY27 earnings call analysis →
- Q1 FY27 earnings call analysis →
- Q2 FY26 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q1 FY26 earnings call →
- Q3 FY25 earnings call →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
- Q1 FY24 earnings call →
Others in Insurance this season
- Max Financial Services Ltd (Q4 FY25)
Individual adjusted first year premium grew 20% in FY '25, surpassing private sector growth of 15% and industry growth of 10%. Key concall takeaways from Max…
- Niva Bupa Health Insurance Company Ltd (Q4 FY25)
The company achieved a 32% growth in Gross Written Premium (GWP) on a like-to-like basis in FY25. Key concall takeaways from Niva Bupa Health Insurance Company…
- Medi Assist Healthcare Services Ltd (Q4 FY25)
Growth driven by expansion in both group and retail segments, with group premiums growing 12.4% FY '24 to FY '25 vs industry 10.5%, and retail premiums growing…
Arthneeti Pro · Annual
ICICI Lombard and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were ICICI Lombard Q4 FY25 results?
Expectation of mid-single-digit growth in new Motor sales, with continued competition impacting growth rates. The company expects a positive growth outlook for FY2026 amid some industry challenges.
What is ICICI Lombard share price analysis?
ICICI Lombard currently shows a neutral. The stock trades at a P/E of 33.5 with a market cap of ₹81,423 Cr. Investors should review the full earnings analysis for detailed insights.
Is ICICI Lombard planning capital expenditure?
The document does not explicitly mention any specific current or future capex, capital investment, or strategic investment plans by ICICI Lombard General Insurance Co.
Keep ICICI Lombard on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
